NAGE Q1 2017 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-54.1% YoY

Gross Profit

$2M48.0% margin

Operating Income

-$2M-52.6% margin

Net Income

-$2M-57.3% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-40.3%

Cash Flow

Operating Cash Flow

-$51,000

Free Cash Flow

-$397,000

Stock-Based Comp.

$320,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$12M

Stockholders' Equity

$9M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$7M	-54.1%
Gross Profit	$2M	$3M	-53.1%
Operating Income	-$2M	$454,066	-490.5%
Net Income	-$2M	$255,625	-854.6%